Clinical trials: Methylene Blue
- Condition Methylene Blue
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Acquired Methaemoglobinaemia
MEthylene Blue In Patients With Acquired Methemoglobinemia
This is an open label, uncontrolled, Phase 4 study including 10 patients who present in hospital/urgent care setting with acquired methemoglobinemia.
- Trial name
- MEBIPAM (NCT03395223)
- Testing
- Methylene Blue
- Where
- France
- Volunteers
- 7 people
- Sponsor
- Provepharm SAS
Adverse Effects in the Therapeutic Use of Plasma Substitutes
A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma
The objective of this non-interventional study is to gather data on adverse reactions occurring with Methylene Blue plasma administered in a routine clinical practice environment; to know more about their characteristics and…
- Trial name
- NCT02007473
- Where
- 4 sites in Belgium, Greece and 2 more
- Volunteers
- 8 people
- Sponsor
- Maco Productions S.A.S.